Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

editorial

. 2017 Nov 6;11:1957–1966. doi: 10.2147/OPTH.S145732

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Patel et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Experience of retina specialists of treatment responses during chronic treatment for nAMD with anti-VEGF therapy, 2016 Global Trends in Retina Survey.

Notes: *Members of 39 retina societies throughout the world participated in the 2016 Global Trends in Retina Survey conducted by the American Society of Retina Specialists (ASRS). The US response category reflects US ASRS members’ answers to the same question in the 2016 ASRS Preferences and Trends Survey. Reproduced with permission from the ASRS.²⁷

Abbreviations: anti-VEGF, anti-vascular endothelial growth factor; nAMD, neovascular age-related macular degeneration.